{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:40:01Z","timestamp":1778110801133,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuropharm.2015.06.018","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T17:53:35Z","timestamp":1436118815000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line"],"prefix":"10.1016","volume":"99","author":[{"given":"Diana","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia X.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit","family":"Doudney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.06.018_bib1","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bit.21882","article-title":"Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures","volume":"101","author":"Backliwal","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S1092852900014681","article-title":"Suicide in bipolar disorder: risks and management","volume":"11","author":"Baldessarini","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tips.2007.02.005","article-title":"Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms","volume":"28","author":"Calabresi","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib5","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1471-4159.2000.0742041.x","article-title":"Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices","volume":"74","author":"Cardenas","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W","article-title":"5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response","volume":"15","author":"Cryan","year":"2000","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1526-4610.1996.3610579.x","article-title":"The actions of valproate and neurosteroids in a model of trigeminal pain","volume":"36","author":"Cutrer","year":"1996","journal-title":"Headache: J. Head Face Pain"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nn.3039","article-title":"Serotonergic transcriptional networks and potential importance to mental health","volume":"15","author":"Deneris","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib11","first-page":"15","article-title":"The relevance of monitoring lamotrigine serum concentrations in chronic pain patients","volume":"106","author":"Devulder","year":"2006","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib13","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.0505394102","article-title":"Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia","volume":"102","author":"Dong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/dbio.1995.1205","article-title":"Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization","volume":"170","author":"Eaton","year":"1995","journal-title":"Dev. Biol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bcp.2005.02.012","article-title":"Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives","volume":"69","author":"Eyal","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.WNF.0000228209.69524.E8","article-title":"Therapeutic monitoring of valproate in psychiatry: how far have we progressed?","volume":"29","author":"Fleming","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S1461145708009231","article-title":"Treatment of bipolar disorder: a systematic review of available data and clinical perspectives","volume":"11","author":"Fountoulakis","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11064-006-9201-0","article-title":"Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms","volume":"32","author":"Foxton","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpsychires.2008.12.006","article-title":"Histone deacetylase inhibitors and candidate gene expression: an in\u00a0vivo and in\u00a0vitro approach to studying chromatin remodeling in a clinical population","volume":"43","author":"Gavin","year":"2009","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib20","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1176\/ajp.152.11.1635","article-title":"Relapse and impairment in bipolar disorder","volume":"152","author":"Gitlin","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(03)00161-7","article-title":"Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up","volume":"81","author":"Goldberg","year":"2004","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/jama.290.11.1467","article-title":"Suicide risk in bipolar disorder during treatment with lithium and divalproex","volume":"290","author":"Goodwin","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib23","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/mol.109.061333","article-title":"Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?","volume":"77","author":"Grayson","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","article-title":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","volume":"60","author":"Guidotti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1096\/fj.04-3425fje","article-title":"Association of valproate-induced teratogenesis with histone deacetylase inhibition in\u00a0vivo","volume":"19","author":"Gurvich","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000119064","article-title":"Changes in plasma tetrahydrobiopterin levels of depressives in depressive and remission phases - Reconfirmed by measurement with an internal standard","volume":"29","author":"Hashimoto","year":"1994","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ng1966","article-title":"Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome","volume":"39","author":"Heintzman","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cne.10976","article-title":"Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and \u03b3-aminobutyric acid neurons","volume":"468","author":"Jankowski","year":"2004","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.mp.4001920","article-title":"Serotonergic vulnerability and depression: assumptions, experimental evidence and implications","volume":"12","author":"Jans","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","article-title":"Therapeutic drug monitoring of the newer antiepileptic drugs","volume":"25","author":"Johannessen","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2164-13-424","article-title":"H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells","volume":"13","author":"Karmodiya","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0021-9258(18)51786-5","article-title":"Studies on the structure of the primary oxidation product formed from tetrahydropteridines during phenylalanine hydroxylation","volume":"239","author":"Kaufman","year":"1964","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(90)90416-7","article-title":"Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons","volume":"116","author":"Kelly","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","article-title":"Valproic acid, a molecular lead to multiple regulatory pathways","volume":"53","author":"Kostrouchova","year":"2007","journal-title":"Folia Biol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib39","first-page":"4163","article-title":"The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel","volume":"27","author":"Kuwajima","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031573","article-title":"Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression","volume":"7","author":"Larsson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib41","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Li","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib43","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1128\/MCB.21.23.7913-7922.2001","article-title":"Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation","volume":"21","author":"Lorincz","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.153.2.198","article-title":"Carbamazepine vs lithium in the treatment and prophylaxis of mania","volume":"153","author":"Lusznat","year":"1988","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004052","article-title":"Valproate for acute mood episodes in bipolar disorder","volume":"1","author":"Macritchie","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(02)01711-9","article-title":"DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNA","volume":"445","author":"Manev","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/tpj.2010.23","article-title":"A\u00a0polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants","volume":"11","author":"McHugh","year":"2011","journal-title":"Pharmacogen. J."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/FPC.0b013e328328f82c","article-title":"Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder","volume":"19","author":"McHugh","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jnr.21482","article-title":"Proteomic analysis of embryonic stem cell\u2013derived neural cells exposed to the antidepressant paroxetine","volume":"86","author":"McHugh","year":"2008","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","article-title":"Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture","volume":"237","author":"McLean","year":"1986","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib53","series-title":"Progress in Brain Research","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","article-title":"The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease","author":"Michelsen","year":"2008"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2005.03040.x","article-title":"Histone deacetylase inhibitors decrease reelin promoter methylation in\u00a0vitro","volume":"93","author":"Mitchell","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib56","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/1471-2407-10-366","article-title":"Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists","volume":"10","author":"Mossman","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib58","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1093\/nar\/29.22.4598","article-title":"Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation","volume":"29","author":"Nguyen","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib59","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1074\/jbc.M606773200","article-title":"Cross-talk between histone modifications in response to histone deacetylase inhibitors","volume":"282","author":"Nightingale","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib60","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/npp.2009.188","article-title":"Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes","volume":"35","author":"Perisic","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib61","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib62","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1528-1157.1999.tb02029.x","article-title":"The pharmacologic basis of antiepileptic drug action","volume":"40","author":"Rho","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11064-006-9233-5","article-title":"Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder","volume":"32","author":"Richardson","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib64","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11936-013-0236-7","article-title":"Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment","volume":"15","author":"Rodriguez-Sainz","year":"2013","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib65","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1101\/gad.1272505","article-title":"Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping","volume":"19","author":"Roh","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.virol.2010.12.007","article-title":"Dynamic control of endogenous retroviruses during development","volume":"411","author":"Rowe","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib67","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01080","article-title":"Active genes are tri-methylated at K4 of histone H3","volume":"419","author":"Santos-Rosa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib69","first-page":"215","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation","volume":"14","author":"Segawa","year":"1976","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.schres.2006.07.015","article-title":"Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population","volume":"88","author":"Sharma","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib71","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2014.01.037","article-title":"Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia","volume":"265","author":"Singh","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib73","doi-asserted-by":"crossref","first-page":"159761","DOI":"10.4061\/2010\/159761","article-title":"Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder","volume":"2010","author":"Squassina","year":"2010","journal-title":"Hum. Genomics Proteomics"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib74","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1038\/tp.2011.61","article-title":"Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders","volume":"1","author":"Tang","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib75","doi-asserted-by":"crossref","first-page":"13660","DOI":"10.1074\/jbc.M807959200","article-title":"GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression","volume":"284","author":"Tatham","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib76","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm1490","article-title":"GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence","volume":"12","author":"Tegeder","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib77","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1042\/BST0371126","article-title":"Structure-function studies for the panacea, valproic acid","volume":"37","author":"Terbach","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3470001","article-title":"Tetrahydrobiopterin biosynthesis, regeneration and functions","volume":"347","author":"Thony","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib79","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib80","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/11596280-000000000-00000","article-title":"Combination therapy for neuropathic pain a review of current evidence","volume":"25","author":"Vorobeychik","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng1990","article-title":"Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome","volume":"39","author":"Weber","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib83","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1523\/JNEUROSCI.14-11-06744.1994","article-title":"Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons","volume":"14","author":"White","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(93)91111-5","article-title":"Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe","volume":"615","author":"Whittemore","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/meth.1995.1034","article-title":"Phenotypic diversity in neuronal cell lines derived from raphe nucleus by retroviral transduction","volume":"7","author":"Whittemore","year":"1995","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuropharm.2008.09.019","article-title":"Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation","volume":"56","author":"Yu","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.06.018_bib87","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1046\/j.1471-4159.2003.02275.x","article-title":"DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: evidence in human NT2 and NT2-N cells","volume":"88","author":"Zhang","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.06.018_bib88","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1038\/sj.onc.1204970","article-title":"Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells","volume":"20","author":"Zhu","year":"2001","journal-title":"Oncogene"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T01:24:16Z","timestamp":1748481856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815300046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":88,"alternative-id":["S0028390815300046"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}